BVF Partners OS Ltd., Insider at Nivalis Therapeutics, Inc. (NVLS), bought 72,650 shares at $2.29 ($166K) on 2017-06-05, disclosed to the SEC on 2017-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.29 | 3,920 | $9K | 5.4% |
| 2 | $2.29 | 12,624 | $29K | 17.4% |
| 3 | $2.29 | 19,206 | $44K | 26.5% |
| 4 | $2.28 | 3,673 | $8K | 5.0% |
| 5 | $2.28 | 13,046 | $30K | 17.9% |
| 6 | $2.28 | 20,181 |
| $46K |
| 27.7% |
| Total | $2.28 avg | 72,650 | $166K | 100% |
| Filing → |
| XOMA | BUY | 2020-09-23 | $1.8M | — | Filing → |
| IDYA | BUY | 2020-06-22 | $3.4M | — | Filing → |
| FPRX | BUY | 2019-12-26 | $4.2M | — | Filing → |